Streetbeat News

Products Services

GOOG

GOOGL

META

Meta Platform Inc.'s Instagram is testing a new 'ad breaks' feature that forces users to watch ads before continuing to scroll. This move aims to drive value for advertisers and follows similar trends seen on platforms like YouTube.

Portfolio Pulse from Franca Quarneti

June 03, 2024 | 9:06 pm

FANG

Diamondback Energy's joint venture, Deep Blue, has acquired Lagoon Operating – Midland, LLC to enhance its sustainable water management capabilities in the Midland Basin. The terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:51 pm

FGEN

REGN

FibroGen Inc (NASDAQ:FGEN) shares surged in after-hours trading following the FDA's clearance of its Investigational New Drug (IND) for FG-3165 and a new clinical trial supply agreement with Regeneron Pharmaceuticals (NASDAQ:REGN). FG-3165 is a galectin-9 targeted monoclonal antibody for treating solid tumors. Phase 1 trials are set to begin in the second half of 2024.

Portfolio Pulse from Adam Eckert

June 03, 2024 | 8:48 pm

SHFS

Safe Harbor Financial Services Inc. (NASDAQ:SHFS) is revolutionizing the cannabis banking industry with its 'Lead with Lending' strategy, resulting in a 245% increase in net income for Q1. The company is focusing on expanding its credit programs and developing new payment solutions, while also preparing for potential changes in cannabis regulation.

Portfolio Pulse from Patricio Liddle

June 03, 2024 | 8:24 pm

SHOT

Safety Shot, Inc. (NASDAQ:SHOT) has announced a strategic partnership with Mr. Checkout to expand its presence with independent retailers nationwide. This partnership aims to provide more access for consumers in diversified retail locations.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:23 pm

SNY

Sanofi's IMROZ Phase 3 study shows that Sarclisa combined with VRd reduces the risk of disease progression or death by 40% in newly diagnosed transplant-ineligible multiple myeloma patients. This is the first global Phase 3 study of anti-CD38 with VRd to improve progression-free survival (PFS) and show deep responses. The results were presented at ASCO and published in NEJM.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:21 pm

BLK

GBTC

Cryptocurrency markets have started the week in green, with notable gains in Bitcoin, Solana, and Dogecoin. Ethereum spot ETFs are anticipated to impact the market. Bitcoin's short liquidations peaked, and Wisconsin revealed owning Bitcoin through BlackRock and Grayscale ETFs.

Portfolio Pulse from Khyathi Dalal

June 03, 2024 | 8:20 pm

INGN

Inogen, Inc. (NASDAQ:INGN) published a study in the journal Pulmonary Therapy showing that portable oxygen concentrators (POCs) are associated with increased survival and cost-effectiveness compared to other long-term oxygen therapies. The study, using data from the French national healthcare system, analyzed over 244,000 patients and found that POCs improved survival rates and had similar healthcare resource use compared to stationary concentrators, compressed tanks, and liquid oxygen.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:20 pm

OABI

OmniAb announced the publication of a peer-reviewed paper in the Journal of Immunology. The paper discusses engineered chickens producing single-domain antibodies (sdAbs), which form the basis of OmniAb's novel transgenic chicken platform, OmnidAb™, launched in 2023.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:15 pm

MYGN

Myriad Genetics' Patient-Outcomes Study validating RiskScore as a clinical breast cancer risk assessment tool has been published in Medical Genetics and Genomics.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:13 pm